The expression of Fas and Fas ligand, and the effects of interferon in chronic liver diseases with hepatitis C virus.
In viral hepatitis, binding of Fas ligand (FasL) with Fas expressed on the surfaces of infected hepatocytes induces apoptosis, removing hepatitis virus along with infected hepatocytes. We measured serum concentrations of soluble Fas (sFas) and FasL (sFasL), expression of membrane-bound FasL, and expression of FasL-mRNA in patients with chronic hepatitis C without cirrhosis (CH-C) and chronic hepatitis C with liver cirrhosis (LC-C). In CH-C, sFasL concentrations were lower and FasL-mRNA expression was significantly less than in volunteers. In LC-C, sFas concentrations were significantly greater than in healthy volunteers, while sFasL, membrane-bound FasL expression, and FasL-mRNA expression did not show significant differences. We also examined these variables over 24 h following the first interferon (IFN) treatment in patients with CH-C. Serum concentrations of sFas and sFasL, and FasL-mRNA expression increased markedly beyond amounts present before IFN injection until 12 h after IFN injection. However, membrane-bound FasL expression decreased until 6 h, followed by an increase until 24 h. Our findings suggest that the ratio of membrane-bound FasL to sFasL may be regulated to remove virally infected cells in CH-C. In addition, apoptosis mediated by the Fas/FasL system may be influenced by IFN injection for treatment of CH-C.
Yoneyama
Kazuo
K
First Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, 010-0041, Akita, Japan
Goto
Takashi
T
Miura
Kouichi
K
Mikami
Ken ichirou
K
Ohshima
Shigetoshi
S
Nakane
Kunio
K
Lin
Jiun Guey
JG
Sugawara
Masashiro
M
Nakamura
Norio
N
Shirakawa
Kamon
K
Komatsu
Masafumi
M
Watanabe
Sumio
S